stopping b12 injections Your energy matters 🩵 Walk-Ins for NAD+ & start this Friday January 3rd! Stop by and start your new year feeling refreshed ✨ Bijou Body Spa 1935 W 95th st 📍 How to Give a B12

AOD 9604 vs Tirzepatide: Summarizing Key Differences Fat Loss Mechanism AOD 9604: Direct lipolysis stimulation and lipogenesis inhibition Tirzepatide: Caloric deficit from appetite suppression plus metabolic optimization Appetite Impact AOD 9604: No significant effect Tirzepatide: Powerful suppression via GLP-1/GIP pathways Metabolic Pathway AOD 9604: Beta-3 adrenergic receptor activation (and likely additional pathways) in adipose tissue Tirzepatide: GLP-1 and GIP receptor agonism affecting glucose metabolism and insulin secretion Evidence Base AOD 9604: Primarily animal studies with mechanistic data Tirzepatide: Extensive human clinical trials with proven outcomes Timeline AOD 9604: 4-6+ weeks for visible effects in animal models Tirzepatide: Progressive weight loss documented across clinical trial periods over as long as 72 weeks How to Choose Between AOD 9604 and Tirzepatide Stop looking for the best peptide and start asking which mechanism addresses YOUR specific physiology

Please consult a licensed healthcare provider before making any medical decisions.

in less deficient areas, every 56 months or as necessary

Our professional team delivers the same high-quality B12 infusion therapy without the hassle of clinic visits, allowing you to feel your best without disrupting your busy schedule

Structure Difference AOD 9604 is formed from a fragment of human growth hormone (176-191)

Not as an independent driver of weight loss the evidence for that is weak